Skip to main content
SpringerLink
Log in

Kinetics and Pattern of Degradation of Thyrotropin-Releasing Hormone (TRH) in Human Plasma

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The kinetics and mechanism of degradation of the tripeptide TRH (pGlu-His-Pro-NH2) and its various primary and secondary degradation products (TRH-OH, His-Pro-NH2, and His-Pro) have been determined in human plasma at 37°C. The rates of degradation of both TRH and TRH-OH (pGlu-His-Pro) showed mixed zero-order and first-order kinetics. At low substrate concentrations first-order kinetics occurred, with TRH and TRH-OH degradation half-lives of 9.4 and 27 min, respectively. The initial step in the plasma-catalyzed degradation of TRH is due to hydrolysis of the pGlu-His bond by the TRH-specific pyroglutamyl aminopeptidase serum enzyme, resulting in the exclusive formation of histidyl-proline amide (His-Pro-NH2). Using specific HPLC methods the major degradation route (67%) of this dipeptide in human plasma was hydrolysis of the peptide bond to yield His and Pro-NH2, whereas deamidation to yield His-Pro accounted for 29% of the total degradation. A minor pathway (≤4%) was spontaneous cyclization to yield cyclo(His-Pro). Both His-Pro-NH2 and His-Pro degraded by first-order kinetics and faster than TRH, with half-lives of 5.3 and 2.2 min, respectively, in 80% plasma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. G. Metcalf. Brain Res. Dev. 4:389–408 (1982).

    Google Scholar 

  2. I. M. D. Jackson. N. Engl. J. Med. 306:145–155 (1982).

    Google Scholar 

  3. E. C. Griffiths. Psychoneuroendocrinology 10:225–235 (1985).

    Google Scholar 

  4. E. C. Griffiths. Nature 322:212–213 (1986).

    Google Scholar 

  5. E. C. Griffiths. Clin. Sci. 73:449–457 (1987).

    Google Scholar 

  6. A. Horita, M. A. Carino, and H. Lai. Annu. Rev. Pharmacol. Toxicol. 26:311–332 (1986).

    Google Scholar 

  7. P. T. Loosen. Progr. Neuro-Psychopharmacol. Biol. Psychiat. 12:S87–S117(1988).

    Google Scholar 

  8. M. Hichens. Drug Metab. Rev. 14:77–98 (1983).

    Google Scholar 

  9. R. M. Bassiri and R. D. Utiger. J. Clin. Invest. 52:1616–1619 (1973).

    Google Scholar 

  10. J. E. Morley, T. J. Garvin, A. E. Pekary, R. D. Utiger, M. G. Nair, C. M. Baugh, and J. M. Hershman. J. Clin Endocrinol. Metab. 48:377–380 (1979).

    Google Scholar 

  11. L. Duntas, F. S. Keck, and E. F. Pfeiffer. Dtsch. Med. Wschr. 113:1354–1357 (1988).

    Google Scholar 

  12. E. Iversen. J. Endocrinol. 118:511–516 (1988).

    Google Scholar 

  13. K. Bauer. Biochimie 70:69–74 (1988).

    Google Scholar 

  14. K. Bauer. In E. C. Griffiths and G. W. Bennett (eds.), Thyrotropin-Releasing Hormone, Raven Press, New York, 1983, pp. 103–118.

    Google Scholar 

  15. T. C. Friedman and S. Wilk. J. Neurochem. 46:1231–1239 (1986).

    Google Scholar 

  16. M. Safran, C.-F. Wu, and C. H. Emerson. Endocrinology 110:2101–2106 (1982).

    Google Scholar 

  17. S. Wilk. Life Sci. 33:2149–2157 (1983).

    Google Scholar 

  18. K. Bauer, K. J. Gräf, A. Faivre-Bauman, S. Beier, A. Tixier-Vidal, and H. Kleinkauf. Nature 274:174–175 (1978).

    Google Scholar 

  19. K. Bauer and P. Nowak. Eur. J. Biochem. 99:239–245 (1979).

    Google Scholar 

  20. K. Bauer, P. Nowak, and H. Kleinkauf. Eur. J. Biochem. 118:173-176 (1981).

    Google Scholar 

  21. W. L. Taylor and J. E. Dixon. J. Biol. Chem. 253:6934–6940 (1978).

    Google Scholar 

  22. C. H. Emerson, A. Mishal, H. L. Mahabeer, and B. L. Currie. J. Clin. Endocrinol. Metab. 49:138–140 (1979).

    Google Scholar 

  23. C. Prasad. Neurosci. Biobehav. Rev. 12:19–22 (1988).

    Google Scholar 

  24. J. Møss and H. Bundgaard. J. Pharm. Pharmacol. 42:7–12 (1990).

    Google Scholar 

  25. E. C. Griffiths, J. R. McDermott, and T. J. Visser. In E. C. Griffiths and G. W. Bennett (eds.), Thyrotropin-Releasing Hormone, Raven Press, New York, 1983, pp. 85–94.

    Google Scholar 

  26. H. Bundgaard. In S. S. Davis, L. Illum, and E. Tomlinson (eds.), Delivery Systems for Peptide Drugs, Plenum Press, New York, 1986, pp. 49–68.

    Google Scholar 

  27. H. Bundgaard and J. Møss. Biochem. Soc. Trans. 17:947–949 (1989).

    Google Scholar 

  28. P. J. Coggins, J. R. McDermott, and C. R. Snell. Neuropeptides 9:83–91 (1987).

    Google Scholar 

  29. C. Prasad, A. Jayaraman, H. Robertson, and J. Rao. Neurochem. Res. 12:767–775 (1987).

    Google Scholar 

  30. A. Peterkofsky, F. Battaini, Y. Koch, Y. Takahara, and P. Dannies. Mol. Cell. Biochem. 42:45–63 (1982).

    Google Scholar 

  31. R. Schuster. J. Chromatogr. 431:271–284 (1988).

    Google Scholar 

  32. I. H. Segel. In Enzyme Kinetics, Wiley-Interscience, New York, 1975, pp. 18–57.

    Google Scholar 

  33. G. Thomas, J.-C. Thalabad, and C. Girre. TIPS 8:292–294 (1987).

    Google Scholar 

  34. T. J. Visser, W. Klootwijk, R. Docter, and G. Hennemann. Acta Endocrinol. 86:449–456 (1977).

    Google Scholar 

  35. R. Bassiri and R. D. Utiger. Endocrinology 91:657–664 (1972).

    Google Scholar 

  36. P. Virkkunen. Acta Physiol. Scand. 92:416–420 (1974).

    Google Scholar 

  37. D. Brewster and K. Waltham. Biochem. Pharmacol. 30:619–622 (1981).

    Google Scholar 

  38. J. C. Dvorak and R. D. Utiger. J. Clin. Endocrinol. Metab. 44:582–585 (1977).

    Google Scholar 

  39. D. Brewster, M. J. Humphrey, and M. V. Wareing. Neuropeptides 1:153–165 (1981).

    Google Scholar 

  40. P. T. Loosen, W. Youngblood, and B. Dew. Pharmacopsychiatry 18:325–329 (1985).

    Google Scholar 

  41. K. M. Knigge and D. Schock, Neuroendocrinology 19:277–287 (1975).

    Google Scholar 

  42. M. Safran, C.-F. Wu, R. Matys, S. Alex, and C. H. Emerson. Endocrinology 115:1031–1037 (1984).

    Google Scholar 

  43. M. G. Nair, T. W. Redding, and A. V. Schally. Biochemistry 10:3621–3624 (1971).

    Google Scholar 

  44. T. Matsui, C. Prasad, and A. Peterkofsky. J. Biol. Chem. 254:2439–2445 (1979).

    Google Scholar 

  45. K. Bauer and H. Kleinkauf. Eur. J. Biochem. 106:107–117 (1980).

    Google Scholar 

  46. P. Browne and G. O'Cuinn. J. Biol. Chem. 258:6147–6154 (1983).

    Google Scholar 

  47. P. Browne and G. O'Cuinn. Eur. J. Biochem. 137:75–87 (1983).

    Google Scholar 

  48. B. O'Connor and G. O'Cuinn. Eur. J. Biochem. 154:329–335 (1986).

    Google Scholar 

  49. P. J. Coggins, J. R. McDermott, C. R. Snell, and A. M. Gibson. Neuropeptides 10:147–156 (1987).

    Google Scholar 

  50. J. G. Turner and T. M. Schwartz. J. Chromatogr. 487:275–286 (1989).

    Google Scholar 

  51. C. Prasad and A. Peterkofsky. J. Biol. Chem. 251:3229–3234 (1976).

    Google Scholar 

  52. C. Prasad, T. Matsui, and A. Peterkofsky. Nature 268:142–144 (1977).

    Google Scholar 

  53. D. Brewster and M. J. Rance. Biochem. Pharmacol. 29:2619–2623 (1980).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Chemistry, Royal Danish School of Pharmacy, 2 Universitetsparken, DK-2100, Copenhagen, Denmark

    Judi Møss & Hans Bundgaard

Authors
  1. Judi Møss
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans Bundgaard
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Møss, J., Bundgaard, H. Kinetics and Pattern of Degradation of Thyrotropin-Releasing Hormone (TRH) in Human Plasma. Pharm Res 7, 751–755 (1990). https://doi.org/10.1023/A:1015875824238

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015875824238

Search

Navigation